TCL Archive NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial May 14, 2010
TCL Archive High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer November 27, 2009
TCL Archive Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director September 3, 1976
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
